EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Lipid Metabolism, Lipogenesis, and Resistance to Third Generation EGFR‐TKIs

Wenhao Luo, Zun Wang, Guangzhi Ma, Wang Shen iD, Xiaobo Chen, Yida Liao

Journal of Clinical Laboratory Analysis · 2026-07 · 40 (13)

DOI: 10.1002/jcla.70274 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Clinical Laboratory Analysis, online erschienen am 03.06.2026. Verfasst von Wenhao Luo und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, University of Electronic Science and Technology of China, Chengdu, Sichuan, China. Hauptthemen laut MEDLINE: Lipid Metabolism, Drug Resistance, Neoplasm, Protein Kinase Inhibitors, Lipogenesis. Die Arbeit nennt 144 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Science and Technology Project of Sichuan Provincial Health Commission, Wu Jieping Medical Foundation, Natural Science Foundation of Sichuan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cancer metabolism has emerged as a critical area of study in cancer research. Dysregulated lipid metabolism has been observed in various cancer types, and this metabolic rewiring facilitates tumor growth, metastasis, and treatment resistance. Additionally, aberrant lipid metabolism is associated with poor patient prognosis.

Methods

This review aims to provide a comprehensive overview of cancer metabolism, with a specific focus on lipid metabolism/lipogenesis and its association with resistance to third‐generation epidermal growth factor receptor tyrosine kinase inhibitors (EGFR‐TKIs).

Results

Lipid metabolism/lipogenesis provides cancer cells with energy substrates and building blocks for membrane biogenesis. In parallel, resistance to third‐generation EGFR‐TKIs has emerged as a major challenge in the treatment of non‐small cell lung cancer (NSCLC) driven by EGFR mutations.

Conclusion

Understanding the intricate connections between lipid metabolism/lipogenesis and resistance to third‐generation EGFR‐TKIs is crucial for developing effective therapeutic strategies. Targeting lipid metabolism pathways holds promise as a novel therapeutic approach to overcome treatment resistance and improve patient prognosis. Further research is needed to better understand the underlying mechanisms and identify potential drug targets in lipid metabolism.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lipid MetabolismDrug Resistance, NeoplasmProtein Kinase InhibitorsLipogenesisNeoplasmsHumansErbB ReceptorsLung NeoplasmsAnimalsCarcinoma, Non-Small-Cell Lung

Stichwörter der Autor:innen

cancer metabolismlipid metabolismlipogenesisnon‐small cell lung cancerthird generation EGFR‐TKIstreatment resistance

Substanzen

ErbB ReceptorsProtein Kinase InhibitorsEGFR protein, human

Autor:innen und Institutionen

  • School of Medicine, University of Electronic Science and Technology of China, Chengdu, Sichuan, China.
  • West China School of Stomatology, Sichuan University, Chengdu, Sichuan, China.
  • Department of Thoracic Surgery, West China Hospital of Sichuan University, Chengdu, Sichuan, China.
  • Lung Cancer Center, West China Hospital of Sichuan University, Chengdu, Sichuan, China.
  • Department of Thoracic Surgery, The First Affliliated Hospital of Kunming Medical University, Kunming, Yunnan, China.
  • Department of Thoracic Surgery, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, Sichuan, China.

ORCID-Profile: Wang Shen

Förderung

  • Science and Technology Project of Sichuan Provincial Health Commission
  • Wu Jieping Medical Foundation
  • Natural Science Foundation of Sichuan Province

Zitieren

APA

Luo, W., Wang, Z., Ma, G., Shen, W., Chen, X., & Liao, Y. (2026). Lipid Metabolism, Lipogenesis, and Resistance to Third Generation EGFR‐TKIs. Journal of Clinical Laboratory Analysis, 40(13). https://doi.org/10.1002/jcla.70274

Vancouver

Luo W, Wang Z, Ma G, Shen W, Chen X, Liao Y. Lipid Metabolism, Lipogenesis, and Resistance to Third Generation EGFR‐TKIs. Journal of Clinical Laboratory Analysis. 2026;40(13). doi:10.1002/jcla.70274

BibTeX
@article{Luo2026,
  author = {Luo, Wenhao and Wang, Zun and Ma, Guangzhi and Shen, Wang and Chen, Xiaobo and Liao, Yida},
  title = {Lipid Metabolism, Lipogenesis, and Resistance to Third Generation EGFR‐TKIs},
  journal = {Journal of Clinical Laboratory Analysis},
  year = {2026},
  volume = {40},
  number = {13},
  doi = {10.1002/jcla.70274}
}
Kostenlos starten →